Using MRI to Track Gene Therapy for Atherosclerosis
Author Information
Author(s): Sun Jihong, Li Xubin, Feng Hongqing, Gu Huidong, Blair Tiffany, Li Jiakai, Soriano Stephanie, Meng Yanfeng, Zhang Feng, Feng Qinghua, Yang Xiaoming
Primary Institution: Zhejiang University School of Medicine, University of Washington School of Medicine
Hypothesis
Can in vivo MRI effectively monitor bone marrow cell-mediated interleukin-10 gene therapy for atherosclerosis?
Conclusion
The study confirmed that MRI can track IL-10/Feridex-BMCs in atherosclerotic lesions, helping to prevent the progression of atherosclerosis.
Supporting Evidence
- IL-10 gene transduction and Feridex labeling of bone marrow cells were successfully achieved with high efficiency.
- MRI showed signal voids in aortic walls due to migrated IL-10/Feridex-BMCs in atherosclerotic plaques.
- Histological analysis confirmed the presence of IL-10 and Feridex-positive cells in atherosclerotic lesions.
Takeaway
Researchers used MRI to see if special cells carrying a gene could help treat heart disease by finding and stopping bad spots in blood vessels.
Methodology
The study involved in vitro and in vivo experiments with atherosclerotic mice, using MRI to track bone marrow cells that were genetically modified to express IL-10.
Limitations
The study did not determine if the bone marrow cells remained undifferentiated or followed differentiation pathways after recruitment.
Participant Demographics
Atherosclerotic apoE−/− mice, 8 weeks old.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website